G
Genomed SA
WSE:GEN
Genomed SA
WSE:GEN
Price:
28.2
PLN
-6.62%
Market Closed
Market Cap:
zł37.2m
Balance Sheet
Balance Sheet Decomposition
Genomed SA
Genomed SA
Balance Sheet Decomposition is not available for
Genomed SA
Genomed SA
Balance Sheet
Genomed SA
Genomed SA
Currency: PLN
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3
|
4
|
4
|
4
|
3
|
4
|
5
|
3
|
5
|
5
|
|
| Cash |
2
|
3
|
3
|
2
|
2
|
4
|
5
|
3
|
5
|
5
|
|
| Cash Equivalents |
1
|
1
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
|
| Accounts Receivables |
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| Total Current Assets |
4
|
5
|
6
|
6
|
7
|
7
|
8
|
8
|
11
|
10
|
|
| PP&E Net |
2
|
2
|
2
|
3
|
2
|
2
|
2
|
2
|
1
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Assets |
6
N/A
|
7
+13%
|
9
+23%
|
9
+9%
|
9
-4%
|
10
+12%
|
10
+3%
|
10
+0%
|
12
+17%
|
12
+2%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
|
| Accrued Liabilities |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Liabilities |
2
|
3
|
2
|
2
|
2
|
2
|
1
|
1
|
2
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+25%
|
3
-8%
|
2
-29%
|
2
-1%
|
2
+40%
|
2
-37%
|
1
-19%
|
2
+66%
|
2
-18%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
0
|
1
|
1
|
1
|
1
|
2
|
9
|
10
|
11
|
|
| Additional Paid In Capital |
4
|
4
|
4
|
6
|
6
|
7
|
7
|
7
|
8
|
9
|
|
| Total Equity |
4
N/A
|
4
+7%
|
6
+42%
|
8
+24%
|
7
-4%
|
8
+5%
|
9
+16%
|
9
+4%
|
10
+10%
|
11
+7%
|
|
| Total Liabilities & Equity |
6
N/A
|
7
+13%
|
9
+23%
|
9
+9%
|
9
-4%
|
10
+12%
|
10
+3%
|
10
+0%
|
12
+17%
|
12
+2%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
